LINC01394: A Potential Cancer, Neurodegenerative, and psychiatric Drug Target

Target Name: LINC01394

NCBI ID: G106144586

LINC01394

Other Name(s): Long intergenic non-protein coding RNA 1394, transcript variant X3 | TCONS_00012639 | LINC01394 variant X3 | long intergenic non-protein coding RNA 1394

LINC01394: A Potential Cancer, Neurodegenerative, and psychiatric Drug Target

LINC01394 is a non-protein coding RNA (ncRNA) molecule located within the intron of the gene ZNF21. It is a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

The ZNF21 gene is a key regulator of stem cell proliferation and differentiation, and is implicated in the development and progression of several diseases, including cancer. LINC01394 is a non-coding RNA molecule that is located within the intron of the ZNF21 gene and has been shown to play a role in regulating stem cell proliferation and differentiation.

Studies have suggested that LINC01394 may be a potential drug target for cancer, due to its involvement in stem cell regulation. LINC01394 has been shown to regulate the expression of genes that are involved in cell cycle progression and apoptosis, which are both processes that are critical for cancer development.

In addition to its potential as a cancer drug target, LINC01394 has also been shown to be involved in the development and progression of neurodegenerative diseases. The ZNF21 gene is known to be involved in the development of several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. LINC01394 has been shown to be expressed in the brains of individuals with these conditions, and may play a role in the development and progression of these diseases.

Furthermore, LINC01394 has also been implicated in the development and progression of psychiatric disorders. The ZNF21 gene is known to be involved in the development and progression of several psychiatric disorders, including depression and anxiety. LINC01394 has been shown to be expressed in the brains of individuals with these conditions, and may play a role in the development and progression of these disorders.

In conclusion, LINC01394 is a non-protein coding RNA molecule that is located within the intron of the ZNF21 gene. It has been shown to play a role in regulating stem cell proliferation and differentiation, and is implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. As a potential drug target and biomarker, LINC01394 may be a valuable tool for the development of new treatments for these diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 1394

The "LINC01394 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01394 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets